| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 99,303 | 109,179 | 114,590 | 111,391 | | Cost of Revenue |
-
| (12,638) | 12,638 | 27,836 | | | Gross Profit |
-
| 121,817 | 101,952 | 83,555 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 46,214 | 76,745 | 49,587 | 36,971 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 7,159 | 8,543 | 10,041 | 11,749 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 36,529 | 42,324 | 34,835 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 7,692 | (2,424) | (16,065) | | Earnings Before Interest And Taxes | 39,603 | 43,645 | 39,927 | 16,288 | | Interest Expense |
-
| 17,300 | 16,663 | 19,126 | | Income Before Tax | 23,458 | 26,345 | 23,264 | (2,838) | | Income Tax Expense | 65,294 | 9,472 | 8,037 | 652 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (41,836) | 16,873 | 15,227 | (3,490) | | | Non-recurring Events | | Discontinued Operations | (231) | 1,052 | (188) | (195) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (42,056) | 17,925 | 15,039 | (3,685) | | Preferred Stock And Other Adjustments | 25 | (95) | 70 |
-
| | | Net Income Applicable To Common Shares | ($42,031) | $17,830 | $15,109 | ($3,685) |
|
0.02% Nasdaq 0.00%
Income Statement
